| Home | E-Submission | Sitemap | Contact Us |  
Korean Journal of Clinical Oncology > Volume 8(1); 2012 > Article
Korean J Clin Oncol. 2012;8(1): 63-67.         doi: https://doi.org/10.14216/kjco.12009
Drug induced interstitial pneumonitis during FOLFOX4 chemotherapy for metastatic colorectal cancer
Jeung-seuk Yoon1, Dong-Guk Park1, Hwan Namgung1, Doh-hyung Kim2
1Department of Surgery, Division of Pulmonology and Allergy, Dankook University College of Medicine, Cheonan, Korea
2Department of Internal Medicine, Dankook University College of Medicine, Cheonan, Korea
Corresponding Author: Hwan Namgung ,Tel: +82-41-550-3929, Fax: +82-41-556-3878, Email: gsnamgung@dankook.ac.kr
Received: March 29, 2012;  Accepted: June 18, 2012.
Share :  
FOLFOX4 regimen is one of the first line treatments for advanced colorectal cancer. Well known adverse effects are neurological, hematologic, and gastro-intestinal toxicities. But recently, there were several case reports about severe form pulmonary toxicity of this regimen. We herein report the case of an additional patient with FOLFOX4 induced interstitial lung disease.
Keywords: Colorectal cancer | FOLFOX4 | Interstitial lung disease
Editorial Office
101-3304 Brownstone Seoul, 464 Cheongpa-ro, Jung-gu, Seoul 100-717, Korea
TEL : +82-2-393-2114   FAX : +82-2-393-1649   E-mail : ksco2004@paran.com

Copyright© Korean Society of Surgical Oncology. All rights reserved.                powerd by m2community
About |  Browse Articles |  Current Issue |  For Authors and Reviewers